The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics Amidst a Pandemic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32463077.
- Also identified by DOI 10.1093/cid/ciaa658 and PMC identifier 7314214.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Medicare does not reimburse for home infusion; patients requiring outpatient parenteral antimicrobial therapy must seek treatment in high-risk settings. We recommend policy change to allow for adequate social distancing during the coronavirus disease 2019 pandemic.
Medical subject headings
- Anti-Bacterial Agents
- COVID-19